Sanjeev M. Raman
( out of 44 reviews )

Sanjeev M. Raman, MBBS, MD

Languages spoken: English, Hindi, Konkani, Marathi, Tamil, French

Clinical Locations

Transplant Center

Transplant Center
Salt Lake City
801-585-3697

  • Sanjeev M. Raman, MD is an Associate Professor of Medicine in the Pulmonary Division, University of Utah School of Medicine. He has been a faculty member in the Pulmonary Division since 2009, when was recruited to the University of Utah to expand its Lung Transplant Program.

    Dr. Raman specializes in the evaluation and care of patients with advanced lung diseases and focuses most of his clinical and research effort on lung transplant recipients. He is one of four transplant pulmonologists in the state of Utah. He is a member of the International Society Of Heart & Lung Transplantation (ISHLT), and is actively involved in various working groups of the ISHLT that collectively publish practice guidelines relevant to the field of lung transplantation.

    His other clinical and research interests include emphysema/ chronic obstructive pulmonary disease (COPD), and he is the primary bronchoscopist and co-investigator for the University of Utah Clinical Center for SPIROMICS ( SubPopulations And InteRmediate Outcome Measures In COPD Study). SPIROMICS is a multi-center study funded by the National Heart, Lung, and Blood Institute (NHLBI) and the COPD Foundation, and supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. Since 2009, it has enrolled approximately 3200 patients across the U.S.

    Dr. Raman is an attending physician at the University of Utah Hospitals and Clinics and provides care to patients on the Pulmonary Medicine inpatient service, the Pulmonary Consult service, as well as the Medical Intensive Care Unit. He is also the Medical Director of the Pulmonology inpatient service, and the "pulmonary ward", where he is involved in quality improvement and safety measures.



    In addition to his clinical activities, he is actively involved in the teaching and training of University of Utah Fellows, Residents, and medical students.

    Dr. Raman was born and raised in Mumbai (formerly Bombay), India, and attended medical school at Grant Medical College & Sir J.J. Group of Hospitals. He subsequently received his medical degree from the University of Mumbai in Mumbai, India. He completed his residency in Internal Medicine at Michigan State University/ Kalamazoo Center for Medical Studies in Kalamazoo, Michigan. He then underwent fellowship training in Pulmonary and Critical Care Medicine at Baylor College of Medicine in Houston, Texas, and at the lung transplant program at The Methodist Hospital, Houston.

    He is Board Certified in Internal Medicine, and in the subspecialties of Pulmonary and Critical Care Medicine. He is also certified by the Educational Commission For Foreign Medical Graduates (ECFMG).

    In his free time, he enjoys reading, photography, and exploring the musical and guitaristic stylings of David Gilmour in a SLC-based Pink Floyd tribute band called "Quiet Desperation".

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    4.9 /5
    ( out of 44 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    March 20, 2024
    UH HOSPITALS AND CLINICS

    Dr Raman took the time to explain things so we could understand them. He answered all of our questions and was willing to spend as much time as needed to help us understand everything about my heath and the transplant process .

    February 18, 2024
    UH HOSPITALS AND CLINICS

    An amazing Doctor , the University and the patients are lucky to have him on staff

    February 10, 2024
    UH HOSPITALS AND CLINICS

    Hes a wonderful man and doctor. Really cares about the pt and takes all the time you need to visit and ask questions. Never in a hurry. I truly appreciate him.

    February 08, 2024
    UH HOSPITALS AND CLINICS

    Excellent Doc, takes the time to explain.

    February 04, 2024
    UH HOSPITALS AND CLINICS

    He is a focused Dr with a straightforward and honest manner yet conveys empathy and concern. I found him very impressive on first meeting and that grew over time.

    January 15, 2024
    UH HOSPITALS AND CLINICS

    He is an awesome Doctor very caring and informative.

    December 10, 2023
    UH HOSPITALS AND CLINICS

    Dr. Roman was excellent in explaining the process of lung transplant. Both the expectations and the risks that involve my two diseases. He was patient and explaining aspects I didn¿t understand, and and being very honest about the expectations and the duration of the process.

    December 07, 2023
    UH HOSPITALS AND CLINICS

    Dr Raman is awesome

    October 12, 2023
    UH HOSPITALS AND CLINICS

    Very good patient doctor relationship couldn¿t ask for a better one

    See More Patient Comments

  • Sanjeev M. Raman, MD is an Associate Professor of Medicine in the Pulmonary Division, University of Utah School of Medicine. He has been a faculty member in the Pulmonary Division since 2009, when was recruited to the University of Utah to expand its Lung Transplant Program.

    Dr. Raman specializes in the evaluation and care of patients with advanced lung diseases and focuses most of his clinical and research effort on lung transplant recipients. He is one of four transplant pulmonologists in the state of Utah. He is a member of the International Society Of Heart & Lung Transplantation (ISHLT), and is actively involved in various working groups of the ISHLT that collectively publish practice guidelines relevant to the field of lung transplantation.

    His other clinical and research interests include emphysema/ chronic obstructive pulmonary disease (COPD), and he is the primary bronchoscopist and co-investigator for the University of Utah Clinical Center for SPIROMICS ( SubPopulations And InteRmediate Outcome Measures In COPD Study). SPIROMICS is a multi-center study funded by the National Heart, Lung, and Blood Institute (NHLBI) and the COPD Foundation, and supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. Since 2009, it has enrolled approximately 3200 patients across the U.S.

    Dr. Raman is an attending physician at the University of Utah Hospitals and Clinics and provides care to patients on the Pulmonary Medicine inpatient service, the Pulmonary Consult service, as well as the Medical Intensive Care Unit. He is also the Medical Director of the Pulmonology inpatient service, and the "pulmonary ward", where he is involved in quality improvement and safety measures.



    In addition to his clinical activities, he is actively involved in the teaching and training of University of Utah Fellows, Residents, and medical students.

    Dr. Raman was born and raised in Mumbai (formerly Bombay), India, and attended medical school at Grant Medical College & Sir J.J. Group of Hospitals. He subsequently received his medical degree from the University of Mumbai in Mumbai, India. He completed his residency in Internal Medicine at Michigan State University/ Kalamazoo Center for Medical Studies in Kalamazoo, Michigan. He then underwent fellowship training in Pulmonary and Critical Care Medicine at Baylor College of Medicine in Houston, Texas, and at the lung transplant program at The Methodist Hospital, Houston.

    He is Board Certified in Internal Medicine, and in the subspecialties of Pulmonary and Critical Care Medicine. He is also certified by the Educational Commission For Foreign Medical Graduates (ECFMG).

    In his free time, he enjoys reading, photography, and exploring the musical and guitaristic stylings of David Gilmour in a SLC-based Pink Floyd tribute band called "Quiet Desperation".

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary/Critical Care - Baylor College of Medicine Fellow
    Internal Medicine - Michigan State University Chief Resident
    Residency Internal Medicine - Michigan State University Resident
    Internal Medicine - Michigan State University Intern
    Professional Medical Medical School - Grant Medical College M.B.B.S.
    Medical School - University of Mumbai, Dr. D.Y. Patil Medical College M.B.B.S.
    Undergraduate R. N Ruia College of Arts & Science Higher Secondary Certificate

    Selected Publications

    Journal Article

    1. Esther CR Jr, ONeal WK, Anderson WH, Kesimer M, Ceppe A, Doerschuk CM, Alexis NE, Hastie AT, Barr RG, Bowler RP, Wells JM, Oelsner EC, Comellas AP, Tesfaigzi Y, Kim V, Paulin LM, Cooper CB, Han MK, Huang YJ, Labaki WW, Curtis JL, Boucher RC Subpopulations and Intermediate Outcome Measures in COPD Study Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD Chest 2022 May16151239-1249 doi 101016jchest202110049 Epub 2021 Nov 18 PMID 34801592 PMCID PMC9131049 (2022). Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD. Chest, 161(5), 1239-1249.
    2. Marczin N, De Waal EEC et al (2021). International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant, 40(11), 1327-1348.
    3. Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O (2021). ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant, 40(11), 1267-1278. (Read full article)
    4. Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O (2021). Bermudez CA, Crespo MM, Shlobin OA, Cantu E, Mazurek JA, Levine D, Gutsche J, Kanwar M, Dellgren G, Bush EL, Heresi GA, Cypel M, Hadler R, Kolatis N, Franco V, Benvenuto L, Mooney J, Pipeling M, King C, Mannem H, Raman S, Knoop C, Douglas A, Mercier O. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant. 2021 Nov;40(11):1267-1278. doi: 10.1016/j.healun.2021.07.016. Epub 2021 Jul 29. PMID: 34404570. J Heart Lung Transplant, 40(11), 1267-1278.
    5. Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176. (Read full article)
    6. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou TG (2018). Longer Life or More Life: Choose One Please. J Surg Res, 237, 126-128. (Read full article)
    7. Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, OBeirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL (2019). Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy. Ann Am Thorac Soc, 16(4), 439-446. (Read full article)
    8. McKellar SH, Bowen ME, Baird BC, Raman S, Cahill BC, Selzman CH (Summer 2016). Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant.J Heart Lung Transplant. 2016 Nov;35(11):1289-1294. doi: 10.1016/j.healun.2016.05.029. Epub 2016 Jun 14. J Heart Lung Transplant, 35(11), 1289-1294.
    9. Couper D1, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S SPIROMICS Research Group Collaborators Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, ONeal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA (2014). Title: Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Authors: Couper D(1), LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S; SPIROMICS Research Group. Collaborators: Alexis N, Anderson W, Badr S, Basta P, Boucher RC, Carretta E, Cooper CB, Curtis J, Doerschuk C, Greenberg J, Hansel N, Kaner R, Kesimer M, Lazarus SC, Meyers D, O'Neal W, Paine R, Peters SP, Raman S, Scholand MB, Sundar K, Tashkin DP, Wise RA, Wright FA. Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD) designed to guide future development of therapies for COPD by providing robust criteria for subclassifying COPD participants into groups most likely to benefit from a given therapy during a clinical trial, and identifying biomarkers/phenotypes that can be used as intermediate outcomes to reliably predict clinical benefit during therapeutic trials. The goal is to enrol 3200 participants in four strata. Participants undergo a baseline visit and three annual follow-up examinations, with quarterly telephone calls. Adjudication of exacerbations and mortality will be undertaken. DOI: 10.1136/thoraxjnl-2013-203897 PMID: 24029743  [Indexed for MEDLINE]. Thorax.

    Review

    1. Liou TG, Raman SM, Cahill BC (2013). Lung transplantation for chronic obstructive pulmonary disease. [Review]. 5, 1-20.

    Book Chapter

    1. Raman SM, Morrell MR (2017). Respiratory Conditions: Dyspnea. In Sole A, Silveira F (Eds.), ISHLT Monograph Series, Volume 10: What to do in case of...A reference Diagnostic Guide in Thoracic Organ Transplantation: Practical Approach to Frequent Scenarios. Addison, TX: International Society for Heart and Lung Transplantation.

    Letter

    1. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. [Letter to the editor]. N Engl J Med, 381(15), 1488-1489. (Read full article)

    Abstract

    1. Cahill BC, Liou TG, Peterson-Short K, Maughan T, Doidge W, Sirandas B, Carlson A, Truax C, Cotiguala L, Raman S, McKellar SH, Selzman CH (April 2017). Post-Lung Transplant Survival After Venous Thromboembolism [Abstract]. ISHLT 37th Annual Meeting and Scientific Sessions, 36(4), S403.

  • News & Podcasts

    News